help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dereli, D.
Right arrow Articles by Yilmaz, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dereli, D.
Right arrow Articles by Yilmaz, C.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 5 2263-2268
Copyright © 2003 by The Endocrine Society

Platelet Dysfunction in Lean Women with Polycystic Ovary Syndrome and Association with Insulin Sensitivity

Didem Dereli, Gokhan Ozgen, Filiz Buyukkececi, Engin Guney and Candeger Yilmaz

Departments of Endocrinology (D.D., G.O., C.Y.) and Hematology (F.B.), Ege University Faculty of Medicine, Uckuyular/Izmir, Turkey 35350; and Department of Endocrinology (E.G.), Adnan Menderes University Faculty of Medicine, Aydin, Turkey 09110

Address all correspondence and requests for reprints to: Didem Dereli M.D., Oyak Sitesi 2/8, Sokak No. 2/13, Uckuyular/Izmir, Turkey 35350. E-mail: dtdereli{at}superonline.com.

Platelet dysfunction and its association with insulin resistance and/or hyperandrogenemia were evaluated in 50 women with polycystic ovary syndrome (PCOS), 50 women with nonclassic congenital adrenal hyperplasia (NC-CAH), and 30 women in the control group. Agonist-induced platelet aggregation was measured. Women with PCOS had significantly higher levels of platelet aggregations induced by ADP (77.4 ± 3.3 vs. 67.3 ± 2.8), collagen (79.7 ± 1.8 vs. 69.1 ± 3.9), and epinephrine (84.7 ± 2.6 vs. 67.8 ± 3.8), compared with controls. However platelet aggregations of women with NC-CAH because of ADP (68.2 ± 4.22), collagen (69.5 ± 5.4), or epinephrine (68.6 ± 4.3) were similar to those in the control group. There were negative correlations between aggregations induced by agonists and the insulin sensitivity in women with PCOS. These correlations also appeared significant after androgen levels with covariance analysis were excluded. These covariance analyses were performed because serum androgen levels might affect platelet function. Any significant correlations were not found between androgen levels and agonist-induced platelet aggregation in women with NC-CAH. We conclude that platelet dysfunction may be an important reason for the possible cardiovascular heart diseases in women with PCOS.

Abbreviations: 17-OHP, 17-OH progesterone; BMI, body mass index; CV, coefficient of variation; DHEAS, dehydroepiandrosterone sulfate; FT, free testosterone; HOMA, homeostasis model assessment; IR, insulin resistance; NC-CAH, nonclassic congenital adrenal hyperplasia; PCOS, polycystic ovary syndrome; PRP, platelet-rich plasma.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
H. Matsuno, H. Tokuda, A. Ishisaki, Y. Zhou, Y. Kitajima, and O. Kozawa
P2Y12 Receptors Play a Significant Role in the Development of Platelet Microaggregation in Patients with Diabetes
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 920 - 927.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society